Discounted Cash Flow
Cross Country Healthcare Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | — | $8.0m | $23.6m | — | $0.25 |
| 2017 | — | $37.5m (370.9%) | $40.4m (71.0%) | — | $1.07 (328.0%) |
| 2018 | $816.5m | $-17.0m (-145.2%) | $16.4m (-59.4%) | -2.1% | $-0.48 (-144.9%) |
| 2019 | $822.2m (0.7%) | $-57.7m (-240.5%) | $2.6m (-84.1%) | -7.0% (-238.1%) | $-1.61 (-235.4%) |
| 2020 | $836.4m (1.7%) | $-13.0m (77.5%) | $22.6m (768.1%) | -1.5% (77.9%) | $-0.36 (77.6%) |
| 2021 | $1.7b (100.5%) | $132.0m (1118.4%) | $-92.8m (-510.8%) | 7.9% (608.0%) | $3.60 (1100.0%) |
| 2022 | $2.8b (67.4%) | $188.5m (42.8%) | $125.3m (235.0%) | 6.7% (-14.7%) | $5.09 (41.4%) |
| 2023 | $2.0b (-28.0%) | $72.6m (-61.5%) | $234.5m (87.2%) | 3.6% (-46.4%) | $2.07 (-59.3%) |
| 2024 | $1.3b (-33.5%) | $-14.6m (-120.0%) | $111.4m (-52.5%) | -1.1% (-130.1%) | $-0.44 (-121.3%) |
| 2025 | $1.1b (-21.6%) | $-94.9m (-551.6%) | $40.1m (-64.0%) | -9.0% (-730.7%) | $-2.93 (-565.9%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.